The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices

AAPS PharmSciTech

Volumn 12, Issue 3, 2011, Pages 862-871

  Palmer, Dasha ^a   Levina, Marina ^a   Nokhodchi, Ali ^b,c   Douroumis, Dennis ^b   Farrell, Tom ^a   Rajabi Siahboomi, Ali ^a  

^a Colorcon Limited ^*  (United States)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

extended release; FT IR; ibuprofen; matrix tablet; polyethylene oxide; polymer combination; propranolol hydrochloride; sodium carboxymethylcellulose; theophylline

Indexed keywords

AMINE; CARBOXYL GROUP; CARBOXYMETHYLCELLULOSE; IBUPROFEN; MACROGOL; POLYMER; PROPRANOLOL; SODIUM CHLORIDE; THEOPHYLLINE;

ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG RELEASE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; STATIC ELECTRICITY; TABLET FORMULATION;

CARBOXYMETHYLCELLULOSE SODIUM; DELAYED-ACTION PREPARATIONS; IBUPROFEN; POLYETHYLENE GLYCOLS; PROPRANOLOL; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; THEOPHYLLINE; WATER;

EID: 80052604395     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9648-4     Document Type: Article

References (54)

1. MJ Vazquez B Perez-Marcos JL Gomez-Amoza R Martinez-Pacheco C Souto A Concheiro 1992 Influence of technological variables on release of drug from hydrophilic matrices Drug Dev Ind Pharm 20 2519 2526
2. H Juarez G Rico L Villafuerte 2001 Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets Int J Pharm 216 115 125 11274813 10.1016/S0378-5173(01)00583-X 1:CAS:528:DC%2BD3MXitFyru7Y%3D (Pubitemid 32232101)
3. H Li RJ Hardy X Gu 2008 Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets AAPS PharmSciTech 9 437 443 18431663 10.1208/s12249-008-9060-x 1:CAS:528: DC%2BC3cXnslGjt7w%3D
4. Tiwari SB, Rajabi-Siahboomi AR. Extended-release oral drug delivery technologies: monolithic matrix systems, from methods in molecular biology, Chapter 11. In: Jain KK, editor. Drug delivery systems, 437. Totowa: Humana; 2008. p. 217-43.
5. JW Moore HH Flanner 1996 Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles Pharm Tech 20 64 74 (Pubitemid 126450495)
6. MW Velasco JL Ford P Rowe AR Rajabi-Siahboomi 1999 Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets J Contr Rel 57 75 85 10.1016/S0168-3659(98)00110-2 1:CAS:528:DyaK1cXotVymtLk%3D (Pubitemid 29005075)
7. SU Choi J Lee YW Choi 2003 Development of a directly compressible poly(ethylene oxide) matrix for the sustained-release of dihydrocodeine bitartrate Drug Dev Ind Pharm 29 1045 1052 14677766 10.1081/DDC-120025863 1:CAS:528:DC%2BD3sXptVOruro%3D (Pubitemid 37499541)
8. M Levina AR Rajabi-Siahboomi 2004 The influence of excipients on drug release from hydroxypropyl methylcellulose matrices J Pharm Sci 93 2746 2754 15389670 10.1002/jps.20181 1:CAS:528:DC%2BD2cXpvV2isbs%3D (Pubitemid 39506625)
9. M Levina A Gothoskar AR Rajabi-Siahboomi 2006 Application of a modelling system in the formulation of extended release hydrophilic matrices Pharm Tech Eur 18 20 26 1:CAS:528:DC%2BD28XovVSisrc%3D (Pubitemid 44043500)
10. Palmer D, Levina M, Rajabi-Siahboomi AR. The influence of in vitro dissolution method on the release of a highly water soluble drug from polyethylene oxide and hypromellose hydrophilic extended release matrices. AAPS annual meeting and exposition. 2008; Atlanta, USA
11. GS Guru P Prasad HR Shivakumar SK Rai 2010 Miscibility studies of polysaccharide xanthan gum/PVP blend J Polym Environ 18 135 140 10.1007/s10924-010-0191-2 1:CAS:528:DC%2BC3cXpslOisLk%3D
12. E Cid F Mella L Lucchini M Carcamo J Monasterio 1986 Plasma concentrations and bioavailability of propranolol by oral, rectal and intravenous administration in man Biopharm Drug Dispos 7 559 566 3828485 10.1002/bdd.2510070605 1:CAS:528:DyaL2sXhvVynsb0%3D (Pubitemid 17033694)
13. B Taylan Y Capan O Guven S Kes AA Hincall 1996 Design and evaluation of sustained release and buccal adhesive propranolol hydrochloride tablets J Control Release 37 11 20 10.1016/0168-3659(95)00094-1 (Pubitemid 26027174)
14. MJ Serlin ML Orme M Maciver GJ Green RG Sibeon AM Beckenridge 1983 The pharmacodynamics and pharmacokinetics of conventional and long acting propranolol in patients with moderate hypertension Brit J Clin Pharmacol 15 519 527 1:STN:280:DyaL3s3jtFajtw%3D%3D (Pubitemid 13124875)
15. NK Ebube AB Jones 2004 Sustained release of acetaminophen from heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers Int J Pharm 272 19 27 15019065 10.1016/j.ijpharm.2003.11.020 1:CAS:528: DC%2BD2cXhs1Giurg%3D (Pubitemid 38293007)
16. T Çaykara S Demirci 2006 Preparation and characterization of blend films of poly(vinyl alcohol) and sodium alginate J Macromol Sci 43 1113 1121 10.1080/10601320600740389 (Pubitemid 43941465)
17. S Conti L Maggi L Segale E Ochoa Machiste U Conte P Grenier G Vergnault 2007 Matrices containing Na CMC and HPMC. 1. Dissolution performance characterization Int J Pharm 333 136 142 17207943 10.1016/j.ijpharm.2006.11.059 1:CAS:528:DC%2BD2sXitV2qurw%3D (Pubitemid 46283280)
18. KC Basavaraju T Damappa SK Rai 2008 Miscibility studies of hydroxypropyl methyl cellulose and poly(ethylene oxide) by viscometry, ultrasonic, and refractometric methods J Macromol Sci 47 417 425 10.1080/00222340801954712 1:CAS:528:DC%2BD1cXkt1Srurk%3D (Pubitemid 351498353)
19. C Rakkappan S Anbalagan 2009 Ultrasonic and FTIR studies on aqueous biodegradable polymer blend solutions Am Eurasia J Sci Res 4 281 284 1:CAS:528:DC%2BC3cXhsl2qs7c%3D
20. LC Feely SS Davis 1988 The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matrices In J Pharm 44 131 139 1:CAS:528:DyaL1cXksl2mur8%3D
21. A Nokhodchi S Norouzi-Sani MR Siahi-Shadbad F Lotfipoor M Saeedi 2002 The effect of various surfactants on the release rate of propranolol hydrochloride from hydroxypropylmethylcellulose (HPMC)-Eudragit matrices Eur J Pharm Biopharm 54 349 356 12445567 10.1016/S0939-6411(02)00120-0 1:CAS:528:DC%2BD38XoslGgurk%3D (Pubitemid 35341837)
22. SK Baveja KV Ranga Rao K Padmaltha Devi 1987 Zero-order release hydrophilic matrix tablets of β-adrenergic blockers Int J Pharm 39 39 45 10.1016/0378-5173(87)90196-7 1:CAS:528:DyaL2sXlvVemsr0%3D (Pubitemid 17130774)
23. S Takka 2003 Propranolol hydrochloride-anionic polymer binding interaction II Farmaco 58 1051 1056 10.1016/S0014-827X(03)00181-2 1:CAS:528:DC%2BD3sXnsValsrc%3D (Pubitemid 37162677)
24. SK Baveja KV Ranga Rao A Singh VK Gombar 1988 Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry Int J Pharm 41 55 62 10.1016/0378-5173(88) 90135-4 1:CAS:528:DyaL1cXhtVWhsLw%3D (Pubitemid 18017606)
25. SK Baveja KV Ranga Rao K Padmaltha Devi 1988 Relationship between gum content and half-life of soluble β-blockers from hydrophilic matrix tablets Int J Pharm 47 133 139 10.1016/0378-5173(88)90224-4 1:CAS:528: DyaL1MXivV2rsw%3D%3D
26. KV Ranga Rao K Padmalatha Devi P Buri 1990 Influence of molecular size and water solubility of the solute on its release from swelling and erosion controlled polymeric matrices J Control Release 12 133 141 10.1016/0168-3659(90) 90089-C (Pubitemid 20123878)
27. JW Lu YL Zhu ZX Gu P Hu J Yu 2006 Electrospinning of sodium alginate with poly(ethylene oxide) Polymer 47 8026 8031 10.1016/j.polymer.2006.09.027 1:CAS:528:DC%2BD28XhtFSnur3F (Pubitemid 44585008)
28. TM Basavaraju SK Rai 2007 Miscibility studies of polysaccharide xanthan gum and PEO (polyethylene oxide) in dilute solution Carbohyd Polym 69 462 466 10.1016/j.carbpol.2007.01.004 1:CAS:528:DC%2BD2sXlt1Kisb8%3D (Pubitemid 46711122)
29. SD Raviprakash KS Rai 2004 Miscibility studies of sodium alginate/poly(vinyl glycol) blend in water by viscosity, ultrasonic and refractive index methods Int J Plast Tech 8 334
30. X Mu MJ Tobyn JN Staniforth 2003 Influence of physiological variables on the in-vitro drug-release behaviour of a polysaccharide matrix controlled release system Drug Dev Ind Pharm 29 19 29 12602489 10.1081/DDC-120016680 1:CAS:528:DC%2BD3sXhtlCrsro%3D (Pubitemid 36205878)
31. TD Reynolds SA Mitchell KM Balwinski 2002 Investigation of the effect of tablet surface area/volume on drug release from hydroxypropyl methylcellulose controlled-release matrix tablets Drug Dev Ind Pharm 28 457 466 12056539 10.1081/DDC-120003007 1:CAS:528:DC%2BD38XktFCkurs%3D (Pubitemid 34547882)
32. P Colombo PL Catellani NA Peppas, et al. 1992 Swelling characteristics of hydrophilic matrices for controlled release: new dimensionless number to describe the swelling and release behavior Int J Pharm 88 99 109 10.1016/0378-5173(92)90307-N 1:CAS:528:DyaK3sXms1OgsQ%3D%3D (Pubitemid 23000412)
33. TD Reynolds SA Mitchell KM Balwinski 2004 Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets Drug Dev. Ind. Pharm 28 4 457 466 10.1081/DDC-120003007
34. M Gibaldi S Feldman 1967 Establishment of sink conditions in dissolution rate determinations-theoretical considerations and applications to non-disintegrating dosage forms J Pharm Sci 56 1238 1242 6059440 10.1002/jps.2600561005 1:CAS:528:DyaF2sXltFWgu78%3D
35. Korsemeyer RW, Peppas NA. Macromolecular and modelling aspects of swelling-controlled systems. In: Mansdorf SZ, Roseman TJ, editors. Controlled release delivery systems. New York: Marcel Dekker; 1983. p. 77.
36. J Siepmann H Kranz R Bodmeier NA Peppas 1999 HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics Pharm Res 16 1748 1756 10571282 10.1023/A:1018914301328 1:CAS:528:DyaK1MXnt1GgsLo%3D (Pubitemid 29530409)
37. PL Ritger NA Peppas 1987 A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs J Cont Rel 5 23 36 10.1016/0168-3659(87)90034-4 1:CAS:528:DyaL2sXkvVeku7o%3D (Pubitemid 17106643)
38. JL Ford K Mitchell PH Rowe DJ Armstrong PNC Elliott C Rostron JE Hogan 1991 Mathematical modelling of drug release from HPMC matrices: effect of temperature Int J Pharm 71 95 104 10.1016/0378-5173(91)90071-U 1:CAS:528:DyaK3MXisFeqt7g%3D
39. M Efentakis A Koutlis M Vlachou 2000 Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems AAPS PharmSciTech 1 1 9 10.1208/pt010434
40. KA Khan 1975 The concept of dissolution efficiency J Pharm Pharmacol 27 48 49 235616 10.1111/j.2042-7158.1975.tb09378.x 1:CAS:528:DyaE2MXhsVCru7o%3D
41. T Higuchi 1961 Rate of release of medicaments from ointment bases containing drugs in suspensions J Pharm Sci 50 874 875 13907269 10.1002/jps.2600501018 1:CAS:528:DyaF38Xhtlahsg%3D%3D
42. T Higuchi 1963 Mechanism of sustained action medication. Theoretical analysis of rate release of solid drugs dispersed in solid matrices J Pharm Sci 52 1145 1149 14088963 10.1002/jps.2600521210 1:CAS:528:DyaF2cXlt1Whsg%3D%3D
43. P Timmin A Delargy C Minchom J Howard 1992 Influence of some process variables on product properties for a hydrophilic matrix controlled release tablet Eur J Pharm Biopharm 38 113 118
44. A Nockhodchi JL Ford P Rowe MH Rubinstein 1996 The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropyl methylcellulose 2208 Int J Pharm 129 21 31 10.1016/0378-5173(95) 04236-9 (Pubitemid 26098733)
45. CV Liew LW Chan AL Ching PWS Heng 2006 Evaluation of sodium alginate as drug release modifier in matrix tablets Int J Pharm 309 25 37 16364576 10.1016/j.ijpharm.2005.10.040 1:CAS:528:DC%2BD28XnvVWnsQ%3D%3D (Pubitemid 43129461)
46. NH Shah JH Lazarus CL Jarwoski 1981 Carboxymethylcellulose: effect of degree of polymerization and substitution on tablet disintegration and dissolution J Pharm Sci 70 611 613 7252800 10.1002/jps.2600700609 1:CAS:528:DyaL3MXksV2gs70%3D (Pubitemid 11035288)
47. AS Hussain RD Johnson P Shivanand MA Zoglio 1994 Effects of blending a non-ionic and an anionic cellulose ether polymer on drug release from hydrophilic matrix capsules Drug Dev Ind Pharm 20 2645 2657 10.3109/ 03639049409042668 1:CAS:528:DyaK2cXlvVOjt70%3D (Pubitemid 24288826)
48. MA Dabbagh JL Ford MH Rubinstein JE Hogan AR Rajabi-Siahboomi 1999 Release for propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydropropylmethylcellulose Pharm Dev Technol 4 313 324 10434277 10.1081/PDT-100101367 1:CAS:528:DyaK1MXkslCrt7o%3D (Pubitemid 29352890)
49. Oren PL, Seidler WMK. Sustained release matrix. 1990; US patent no. 4,968,508.
50. Rogers V, Dor PJM, Fix JA, Kojima H, Sako K. Soluble drug extended release system, 2004; United States patent, US 2004/0091518 A1, 1-14.
51. S Takka S Rajbhandari A Sakr 2001 Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets Eur J Pharm Biopharm 52 75 82 11438426 10.1016/S0939-6411(01)00147-3 1:CAS:528:DC%2BD3MXkvVeksLY%3D (Pubitemid 32594790)
52. IG Tucker GH Ahmed PJ Stewart 1988 The binding of propranolol hydrochloride to sodium carboxymethylcellulose Aust J Hosp Pharm 18 196 199 1:CAS:528:DyaL1cXmtFGrt7Y%3D
53. CV Walker JI Wells 1982 Rheological synergism between ionic and non-ionic cellulose gums Int J Pharm 11 309 322 10.1016/0378-5173(82)90081-3 1:CAS:528:DyaL38XlsFSltr8%3D (Pubitemid 13248856)
54. M Sriwongjanya R Bodmeier 1998 Effect of ion exchange resins on the drug release from matrix tablets Euro J Pharm Biopharm 46 321 327 10.1016/S0939-6411(98)00056-3 1:CAS:528:DyaK1MXks1ertw%3D%3D (Pubitemid 29057680)